Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sanofi Consumer Healthcare India Limited has filed a compliance certificate under SEBI Regulation 74(5) for Q4 FY26 (quarter ended March 31, 2026). The certificate from MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent, confirms that all securities received for dematerialisation during the quarter were properly processed and listed on the relevant stock exchanges (BSE and NSE). The filing is signed by Company Secretary Nikunjkumar Savaliya and dated April 9, 2026.
This is a routine regulatory compliance filing with no direct impact on the company's financial performance or stock price. It simply confirms proper processing of share dematerialisation requests.